Claudia Vallin, DO
Neurology · Weston, FLNPI 1972091262
Payments from drug & device makers
Across 92 payments — averaging $93.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$6K
- Jazz Pharmaceuticals Inc.$758
- UCB, Inc.$512
- AbbVie$157
- AstraZeneca$123
- Argenx US, Inc.$120
- plus $784 from 17 others
What the payments were for
- Speaking & faculty fees$5,60065%
- Food & beverage$2,98735%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 16 | $6,134 |
| Jazz Pharmaceuticals Inc. | 24 | $758 |
| UCB, Inc. | 9 | $512 |
| AbbVie | 2 | $157 |
| AstraZeneca(2 entities) | 6 | $123 |
| Argenx US, Inc. | 1 | $120 |
| EMD Serono, Inc. | 3 | $112 |
| Neurelis, Inc. | 5 | $112 |
| Biogen | 3 | $66 |
| Lundbeck LLC | 3 | $59 |
| TG Therapeutics, Inc. | 2 | $55 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Acadia Pharmaceuticals Inc | 2 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Aucta Pharmaceuticals, Inc. | 2 | $37 |
| Philips North America LLC | 1 | $30 |
| Eisai Inc. | 1 | $28 |
| Johnson & Johnson | 1 | $25 |
| Medtronic | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,587 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Weston
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.